Novogen Limited (KZIA) vs LENZ Therapeutics, Inc. (LENZ)
Novogen Limited and LENZ Therapeutics, Inc. are both Biotechnology companies. Novogen Limited and LENZ Therapeutics, Inc. are of similar size ($117.4M and $111.8M). Novogen Limited has the higher net margin (0.00% vs −586.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Novogen Limited leads on 8 and LENZ Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | KZIA | LENZ | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 93.69% | 65.16% |
| Operating margin | — | (631.70%) | 0.00% |
| Net margin | 0.00% | (586.74%) | 0.00% |
| Free cash flow margin | 0.00% | (532.80%) | 0.00% |
| Return on equity | 0.00% | (59.21%) | (57.72%) |
| Return on assets | 0.00% | (55.52%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack